Primary Site >> Liver Cancer

Gene >> TP63

  • 2000
  • 2001
  • 2004
  • 2005
  • 2006
  • 2007
  • 2009
  • 2010
  • 2011
  • 2013
  • 2015
  • 2016
  • 2017
Ref: Absence of p51 mutation in human hepatocellular carcinoma.
PMID: 10695992
Ref: Correlation between p21(waf1) and p16(INK4a) expression in hepatocellular carcinoma.
PMID: 11282486
Ref: Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.
PMID: 15545229
Ref: The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
PMID: 15543231
Ref: TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
PMID: 15578720
Ref: Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
PMID: 16203738
Ref: Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
PMID: 16872309
Ref: A proteomics analysis of cell signaling alterations in colorectal cancer.
PMID: 17848589
Ref: Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
PMID: 19668228
Ref: Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
PMID: 20403333
Ref: TP63 P2 promoter functional analysis identifies beta-catenin as a key regulator of DeltaNp63 expression.
PMID: 21643019
Ref: Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (DeltaNp63) in squamous cell and urothelial carcinoma.
PMID: 24225756
Ref: The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
PMID: 25885474
Ref: CUL4B, NEDD4, and UGT1As involve in the TGF-beta signalling in hepatocellular carcinoma.
PMID: 27236156
Ref: Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
PMID: 28350813
Ref: Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism.
PMID: 28827783